JFL Life Sciences Reports Quarter-End Results; Total Income Stands at 178 Rs. Lakhs
JFL Life Sciences Limited has released its unaudited financial results for the quarter ended June 30, 2026. The company reported a Net Profit after Tax of 37.75 Rs. Lakhs in the current period.The Board of Directors approved these results, which were reviewed by independent auditors Doshi Doshi & Co. These statements have been prepared according to Indian Accounting Standard 34 "Interim Financial Reporting."
JFL Life Sciences maintains a single reportable segment: Pharmaceuticals Manufacturing. The company's key financial performance metrics across the recent quarters are detailed below (all figures in Rs. Lakhs).
| PARTICULARS | Quarter Ended June 30, 2026 (Unaudited) | Quarter Ended March 31, 2026 | Quarter Ended June 30, 2025 (Unaudited) | Year Ended March 31, 2026 (Audited) |
|---|---|---|---|---|
| Revenue from Operations/Other Income | 1,110.25 | 6,305.44 | 1,158.54 | 13,138.26 |
| Total Income | 178 | 403 | 28 | 690 |
| Net Profit/(Loss) After Tax | 37.75 | 58.86 | 68.15 | 219.80 |
| Equity Earning Per Share (Basic) | - | - | - | 1,287.39 |
Financial and Operational Summary
For the quarter ended June 30, 2026, the company reported a Total Income of 178 Rs. Lakhs. The expenses for this period totaled 1,112.02 Rs. Lakhs, resulting in a Net Profit/(Loss) After Tax of 37.75 Rs. Lakhs.Financial results across various periods show the following trends:
- Total Income: Ranged from 28 Rs. Lakhs (Q ended March 31, 2025) to 13,138.26 Rs. Lakhs (Year Ended March 31, 2026).
- Net Profit After Tax: Showed a positive figure of 219.80 Rs. Lakhs for the full financial year ended March 31, 2026.
The independent auditor confirmed that nothing has come to their attention in the unaudited financial results that suggests the information is materially misstated or lacks required disclosure terms. The management, represented by Managing Director Smiral Ashwinkumar Patel, approved the results on August 10, 2026.
JFLLIFE Stock Price Movement
Today, Jfl Life Sciences Limited shares edged higher to close at ₹13.85 after settling gains of 1.47% in the post-market session. The stock traded a volume of 30,000 shares during the day.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.